Mata Mata Turtle with Squamous Cell Carcinoma Successfully Treated with Sensus Healthcare’s SRT System by Colorado State University Veterinarian
Joins multiple companion animals and a horse successfully treated with SRT BOCA RATON, Fla. , March 24, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that a mata mata turtle has joined the growing list of animal […]
Everything You Need to Know About the Transdermal Infusion System
In December of 2021, Sensus Healthcare announced the arrival of a new alternative to medical and aesthetic injections called TransDermal Infusion®. Approved by the FDA as a Class II biophysical alternative to infusing high weight molecule modalities into the dermis, this new system is changing the way patients receive medical and cosmetic treatments. Keep reading […]
Sensus Healthcare to Present at Two Investment Conferences in March
BOCA RATON, Fla. , March 09, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that management will be presenting at the following investment conferences during March: 34th Annual ROTH Conference, March 13-15 at The Ritz-Carlton, Laguna Niguel. […]
Sensus Healthcare Announces Share Repurchase Program
BOCA RATON, Fla, March 09, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that its Board of Directors has authorized a program to purchase up to $3,000,000 of shares of its Common Stock. Commenting on this new […]
Sensus Healthcare Sells its Sculptura™ Assets to Empyrean Medical Systems for $15 Million in Cash
Sale permits Sensus to focus on the core dermatology market while providing capital for channel expansion BOCA RATON, Fla., March 02, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces it has sold its Sculptura™ assets to Empyrean […]
